Indonesia Over the Counter (OTC) Drugs Market to be dominated by Analgesics through 2028
Increase in chronic diseases is expected to drive the
growth of Indonesia Over the Counter (OTC) Drugs Market in the forecast period,
2024-2028
According to TechSci Research
report, “Indonesia Over the Counter (OTC) Drugs Market
- By
Region, Competition Forecast and Opportunities, 2018-2028,”
the Indonesia Over the Counter (OTC)
Drugs Market is anticipated to grow at an impressive rate in the forecast
period of 2024-2028. This can be attributed to the increase in use of gastrointestinal
drugs. Gastrointestinal issues, such as indigestion, acid reflux, stomach
discomfort, and gastrointestinal infections, are prevalent among the Indonesian
population. The adoption of modern lifestyles, including sedentary habits and
changes in dietary patterns, has led to an increase in gastrointestinal issues.
Consuming spicy or fatty foods, irregular mealtimes, and a lack of dietary
fiber can contribute to digestive problems, resulting in higher demand for
gastrointestinal drugs. Pharmaceutical companies and healthcare providers often
engage in marketing and promotional activities to raise awareness about
gastrointestinal disorders and the available treatment options. These efforts
contribute to increased consumer knowledge and the recognition of
gastrointestinal drugs as viable solutions for managing related health issues.
Many gastrointestinal drugs, such as antacids, antidiarrheals, and laxatives,
are available over the counter in pharmacies and retail outlets. This
accessibility allows consumers to obtain these medications without a prescription,
leading to an increase in self-medication practices for managing
gastrointestinal symptoms.
A major trend in the market is the focus on
sustainable and environmentally friendly practices. Consumers and stakeholders
are increasingly concerned about the environmental impact of products and are
seeking sustainable alternatives. There is a growing emphasis on reducing
packaging waste and promoting eco-friendly packaging in the OTC drugs market.
Companies are exploring sustainable packaging materials, such as biodegradable
or recyclable materials, and optimizing packaging sizes to minimize waste. Additionally,
initiatives like refillable packaging and bulk options are gaining traction.
Proper disposal of expired or unused OTC drugs is gaining attention. There is
an increasing focus on educating consumers about the appropriate disposal
methods to prevent environmental contamination. Some pharmacies and healthcare
facilities offer take-back programs or facilitate the proper disposal of unused
medications. Certifications and standards related to sustainability and
environmental practices are becoming more relevant in the Indonesian OTC drugs
market. Companies that adhere to recognized standards, such as organic
certifications or sustainable sourcing certifications, can gain a competitive
edge and build consumer trust.
A challenge faced by the Indonesia Over the Counter
(OTC) Drugs Market is counterfeit products. Counterfeit OTC drugs refer to
products that may contain incorrect ingredients, incorrect dosages, or harmful
substances. Consuming such products can pose serious health risks to consumers,
as they may not provide the intended therapeutic effects or may cause adverse
reactions and complications. Counterfeit products are intentionally
misrepresented, typically in terms of their identity, source, or composition.
They can negatively impact the reputation and trustworthiness of legitimate OTC
drug brands. When consumers unknowingly purchase counterfeit products that do
not deliver the expected results, it can erode their trust in the brand and
undermine their confidence in the OTC drugs.
Browse over XX
market data Figures spread through XX Pages and an in-depth TOC on "Indonesia Over the Counter (OTC) Drugs Market.”
The Indonesia Over the Counter (OTC) Drugs Market can be segmented by
Product Type, by Route of Administration, by Dosage Form, by Distribution
Channel, by End User, and by region. Based on Route of Administration, the
Indonesia Over the Counter (OTC) Drugs Market can be segmented into Oral,
Topical, and Parenteral. The parenteral route of administration refers to the
administration of drugs directly into the body through non-oral routes,
bypassing the gastrointestinal tract. It involves injecting the drug into the
body using various methods such as intravenous (IV), intramuscular (IM), or
subcutaneous (SC) routes. The parenteral route of administration offers several
advantages, including rapid onset of action, bypassing gastrointestinal
degradation, and greater bioavailability compared to oral administration. It is
often used when the drug's characteristics or the patient's condition
necessitate direct delivery into the bloodstream or muscle tissue.
Based on Distribution Channel, the Indonesia Over the Counter (OTC)
Drugs Market can be segmented into Retail Pharmacy, Hospital Pharmacy, and
E-Pharmacy. Indonesia has experienced a significant increase in internet
penetration and smartphone usage, leading to the growth of e-commerce in
various sectors, including healthcare. The convenience and accessibility of
online shopping have led to the rise of e-pharmacies, allowing consumers to
order OTC drugs and healthcare products from the comfort of their homes.
E-pharmacies in Indonesia offer a wide range of OTC drugs and healthcare
products. Consumers can browse through a vast selection of products, compare
prices, read product descriptions, and make informed purchasing decisions.
Major companies operating in Indonesia
Over the Counter (OTC) Drugs Market are:
- PT Kalbe Farma
Tbk
- PT Kimia Farma
Tbk
- PT Tempo Scan
Pacific Tbk
- PT Sanbe Farma
- PT Phapros Tbk
- Johnson &
Johnson Indonesia PT
- GlaxoSmithKline
Indonesia PT
- PT. Bayer
Indonesia
In 2022, PT
Kalbe Farma Tbk or Kalbe, through its subsidiary PT Forsta Kalmedic Worldwide
(Forsta), held a seminar as a concern for the medical device industry, aimed at
promoting public accessibility and flexibility in the sector.
In 2022, PT
Kalbe Farma Tbk (Kalbe), through its subsidiary PT Bifarma Adiluhung, introduced
the genetic testing services in Indonesia, known as KiddyGENME and PrimeGENME.
Download Free Sample Report
Customers can also request for 10% free customization
on this report.
“Indonesia Over the Counter (OTC) Drugs Market is
expected to grow during the forecast period due to the growing demand for
eco-friendly manufacturing. OTC drug manufacturers in Indonesia are adopting
eco-friendly manufacturing processes to reduce energy consumption, water usage,
and waste generation. By implementing sustainable manufacturing practices, such
as energy-efficient technologies and recycling programs, they are able to
minimize the environmental footprint of the production process and gain consumer
trust. Additionally, the increasing concerns regarding health and rising
expenditure on health and wellness are expected to create lucrative
opportunities for market growth," said Mr. Karan Chechi, Research Director
with TechSci Research, a research-based global management consulting firm.
“Indonesia Over The Counter
Drugs Market By Product Type (Cough,
Cold and Flu, Vitamins, Mineral, and Supplements (VMS), Analgesics,
Gastrointestinal Products, Dermatology Products, Others), By Route of Administration (Oral,
Topical, Parenteral), By Dosage Form (Tablets, Capsules, Liquid &
Solutions, Creams/Lotions/Ointments, Others), By Distribution Channel (Retail
Pharmacy, Hospital Pharmacy, E-Pharmacy), By End User (Adults, Geriatric,
Pregnant Females, Children, Infants), By Region, Competition Forecast &
Opportunities, 2018-2028F,” has evaluated
the future growth potential of Indonesia Over the Counter
(OTC) Drugs Market and provides statistics &
information on market size, structure, and future market growth. The report
intends to provide cutting-edge market intelligence and help decision makers
take sound investment decisions. Besides, the report also identifies and
analyzes the emerging trends along with essential drivers, challenges, and
opportunities in Indonesia Over the Counter (OTC) Drugs Market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel:
+1-646-360-1656
Email:
[email protected]
Website:
https://www.techsciresearch.com